Atlas Trials

Proprotein Convertase Subtilisin Kexin 9 in Rheumatoid Arthritis

Clinical trial NCT05191342 · UNKNOWN

Trial details

NCT number
NCT05191342
Sponsor
First Affiliated Hospital of Harbin Medical University
Status
UNKNOWN
Study type
OBSERVATIONAL
PCSK9
Start date
2021-11-01
Primary completion
2022-11-01
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.